Insulin resistance syndrome: options for treatment.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Southern medical journal (Birmingham, Ala. Print)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007611-199901000-00002PMID 9932820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

  1998cited by this paper
• Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus

  1998cited by this paper
• Management of Dyslipidemia in Adults With Diabetes

  1998cited by this paper
• Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

  1998cited by this paper
• Consensus Development Conference on Insulin Resistance: 5–6 November 1997

  1998cited by this paper
• Cardiac and Glycemic Benefits of Troglitazone Treatment in NIDDM

  1997cited by this paper
• Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions.

  1997cited by this paper
• Is insulin vasculotoxic?

  1997cited by this paper
• Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione Troglitazone

  1997cited by this paper
• Recent advances in the treatment of type II diabetes mellitus.

  1997cited by this paper
• Small LDL, atherogenic dyslipidemia, and the metabolic syndrome.

  1997cited by this paper
• Contraindications to Metformin Therapy in Patients With NIDDM

  1997cited by this paper
• Insulin resistance

  1997cited by this paper
• Endothelial markers in diabetes mellitus.

  1997cited by this paper
• Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.

  1997cited by this paper
• Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non‐insulin‐dependent diabetes

  1997cited by this paper
• Optimization of Glycemic Control by Insulin Therapy Decreases the Proportion of Small Dense LDL Particles in Diabetic Patients

  1997cited by this paper
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

  1997cited by this paper
• Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients.

  1997cited by this paper
• Trivalent chromium and the diabetes prevention program.

  1997cited by this paper
• Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome

  1997cited by this paper
• Endothelial function as a determinant of vascular function and structure: a new therapeutic target.

  1997cited by this paper
• LDL heterogeneity: implications for atherogenicity in insulin resistance and NIDDM

  1997cited by this paper
• Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

  1997cited by this paper
• Sibutramine--a review of clinical efficacy.

  1997cited by this paper
• Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease.

  1997cited by this paper
• The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones.

  1996cited by this paper
• Metformin's Effects on Glucose and Lipid Metabolism in Patients with Secondary Failure to Sulfonylureas

  1996cited by this paper
• A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.

  1996cited by this paper
• Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

  1996cited by this paper
• Cardiovascular risk factors and hyperinsulinemia in elderly men: the Honolulu Heart Program.

  1996cited by this paper
• Insulin resistance and obesity

  1996cited by this paper
• Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

  1996cited by this paper
• Erratum to: Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients

  1996cited by this paper
• Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance.

  1996cited by this paper
• Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

  1996cited by this paper
• Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity.

  1996cited by this paper
• Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

  1996cited by this paper
• Insulin and hypertension: a causal relationship?

  1996cited by this paper
• Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy

  1996cited by this paper
• Hyperinsulinemia as an independent risk factor for ischemic heart disease.

  1996cited by this paper
• Effect of Troglitazone on Insulin Sensitivity and Pancreatic β-Cell Function in Women at High Risk for NIDDM

  1996cited by this paper
• The effects of weight loss on insulin sensitivity, skeletal muscle composition and capillary density in obese non-diabetic subjects.

  1996cited by this paper
• Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects.

  1996cited by this paper
• Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

  1995cited by this paper
• Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men.

  1995cited by this paper
• Prevalence of insulin resistance in essential hypertension

  1995cited by this paper
• The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.

  1995cited by this paper
• Altered insulin resistance is associated with increased dietary weight loss in obese children.

  1995cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• Recent Advances: the Cytochrome P450 Enzymes

  1995cited by this paper
• Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension.

  1994cited by this paper
• Hyperinsulinemia, Insulin Resistance, and Hypertension

  1994cited by this paper
• Effects of a New Oral Hypoglycaemic Agent (CS‐045) on Metabolic Abnormalities and Insulin Resistance in Type 2 Diabetes

  1994cited by this paper
• Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link

  1994cited by this paper
• Insulin Action, Diabetogenes, and the Cause of Type II Diabetes

  1994cited by this paper
• Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

  1994cited by this paper
• Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

  1994cited by this paper
• Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.

  1994cited by this paper
• Hyperandrogenism, insulin resistance and acanthosis nigricans. 10 years of progress.

  1994cited by this paper
• Smoking induces insulin resistance—a potential link with the insulin resistance syndrome

  1993cited by this paper
• Physical fitness and blood pressure

  1993cited by this paper
• Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

  1993cited by this paper
• Metformin Improves Glucose, Lipid Metabolism, and Reduces Blood Pressure in Hypertensive, Obese Women

  1993cited by this paper
• How good a marker is insulin level for insulin resistance?

  1993cited by this paper
• The Sulfonylurea Drug, Glimepiride, Stimulates Glucose Transport, Glucose Transporter Translocation, and Dephosphorylation in Insulin-Resistant Rat Adipocytes In Vitro

  1993cited by this paper
• Hypertension and insulin resistance: role of sympathetic nervous system activity.

  1992cited by this paper
• Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus

  1992cited by this paper
• Pathogenesis of NIDDM: A Balanced Overview

  1992cited by this paper
• Free Radical Activity and Hemostatic Factors in NIDDM Patients With and Without Microalbuminuria

  1992cited by this paper
• Fasting serum insulin levels in essential hypertension. A meta-analysis.

  1992cited by this paper
• Glucose Transporter Number, Function, and Subcellular Distribution in Rat Skeletal Muscle After Exercise Training

  1992cited by this paper
• The Effect of Etomoxir on Insulin Sensitivity in Type 2 Diabetic Patients

  1992cited by this paper
• Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects

  1992cited by this paper
• Biguanides and NIDDM

  1992cited by this paper
• The Acute Effect of Insulin on Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Man

  1991cited by this paper
• Effect of exercise training on insulin sensitivity and glucose metabolism in lean, obese, and diabetic men.

  1991cited by this paper
• Effect of New Oral Antidiabetic Agent CS-045 on Glucose Tolerance and Insulin Secretion in Patients with NIDDM

  1991cited by this paper
• Insulin resistance--mechanisms, syndromes, and implications.

  1991cited by this paper
• Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

  1991cited by this paper
• Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM Patients

  1990cited by this paper
• "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes.

  1990cited by this paper
• The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension.

  1989cited by this paper
• Studies on the assembly of apo B-100-containing lipoproteins in HepG2 cells.

  1988cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM

  1988cited by this paper
• Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus

  1987cited by this paper
• Effect of Physical Training on Insulin Action in Obesity

  1987cited by this paper
• Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects.

  1986cited by this paper
• Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function.

  1985cited by this paper
• Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.

  1984cited by this paper
• Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man

  1981cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.

  1975cited by this paper

• Role and mechanism of specialized pro-resolving mediators in obesity-associated insulin resistance

  2024cites this paper
• Experience of Using Subetta in Management of Type 2 Diabetes Mellitus with Comorbidities (a Case Report)

  2020cites this paper
• Laser Doppler Flowmetry and Fluorescence Spectroscopy Use to Assess the Condition of the Microcirculatory Bed and Tissue Metabolism in Patients with Type 2 Diabetes Mellitus on the Background of Subetta Therapy

  2020cites this paper
• Flavonoids and Insulin-Resistance: From Molecular Evidences to Clinical Trials

  2019cites this paper
• Obesity-related insulin resistance in adolescents: a systematic review and meta-analysis of observational studies

  2017cites this paper
• The association between tuberculosis and the development of insulin resistance in adults with pulmonary tuberculosis in the Western sub-district of the Cape Metropole region, South Africa: a combined cross-sectional, cohort study

  2017cites this paper
• Editorial Bajo peso al nacimiento y síndrome metabólico

  2016cites this paper
• The acute effects of different exercise intensities on Microalbuminuria and insulin sensitivity in obese, sedentary females

  2015cites this paper
• The association between tuberculosis and the development of insulin resistance in adults with pulmonary tuberculosis in the Western Sub-District of the Cape Metropole region

  2015influential citation
• Kapacitet pohrane glikogena i de novo lipogeneza tijekom pretjeranog unosa ugljikohidrata u prehrani čovjeka

  2015cites this paper
• Prognostički čimbenici uspjeha različitih barijatrijskih zahvata

  2015influential citation
• INSULIN AND INSULIN RESISTANCE: NEW MOLECULE MARKERS AND TARGET MOLECULE FOR THE DIAGNOSIS AND THERAPY OF DISEASES OF THE CENTRAL NERVOUS SYSTEM

  2013cites this paper
• A global approach to dissecting lipid-induced impairment of liver gluconeogenesis

  2013cites this paper
• The effect of continuous moderate intensity exercise training combined with high intensity interval training on cardiovascular disease risk factors

  2013cites this paper
• Инсулин и инсулинорезистентность: новые молекулы-маркеры и молекулы-мишени для диагностики и терапии заболеваний центральной нервной системы

  2013cites this paper
• Pioglitazone

  2012cites this paper
• Prevalence of metabolic syndrome using weight and weight indices in an apparently healthy Nigerian population

  2012cites this paper
• Using Gene Expression Signatures to Dissect Insulin Resistance Subtypes

  2011cites this paper
• Comparison of McAuley/fasting insulin indices with ATP III clinical criteria for the diagnosis of insulin resistance in type 2 diabetes mellitus

  2011cites this paper
• Metabolic syndrome in the pediatric population: a short overview

  2009cites this paper
• Evaluation and management of polycystic ovary syndrome.

  2009cites this paper
• [Why fast food should be forbidden in Polish schools?].

  2009cites this paper
• Reduction of Hepatic CEACAM1 Levels: an Early Mechanism of Insulin Resistance Induced by High-Fat Diet

  2008cites this paper
• Hypertriglyceridaemic insulin-resistant obese dog model: effects of high-fat diet depending on age.

  2008cites this paper
• The metabolic syndrome: definition, diagnosis and management.

  2008cites this paper
• PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA MOTRICIDADE (ÁREA DE BIODINÂMICA DA MOTRICIDADE HUMANA)

  2008cites this paper
• Ser312 Fetuin-A Phosphorylation and Its Association with Serum Lipids in Metabolic Syndrome

  2008cites this paper
• Oxidative stress in chronic renal failure: molecular basis of its deleterious effects and therapeutical considerations an experimental and clinical study

  2008cites this paper
• Molecular mechanisms of insulin resistance and associated diseases.

  2007cites this paper
• Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications.

  2007cites this paper
• Actions of Insulin Stimulatory Promotes glucose transport into cells Enhances glycogen synthesis Increases fatty acid synthesis Promotes protein synthesis Modifies cellular differentiation and proliferation Inhibitory Inhibits gluconeogenesis Reduces hepatic glucose output Inhibits

  2006cites this paper
• Mo le ku lar ni me ha niz mi in zu lin ske re zis ten ci je, pre ti los ti i me ta bo lič kog sin dro ma Molecular Mechanisms of Insulin Resistance, Obesity and Metabolic Syndrome

  2006cites this paper
• Mechanisms of dietary restriction in aging and disease.

  2006cites this paper
• Insulin resistance syndrome in children.

  2006cites this paper
• Molecular Mechanisms of Insulin Resistance, Obesity and Metabolic Syndrome

  2006influential citation
• Fatores dietéticos na prevenção e tratamento de comorbidades associadas à síndrome metabólica

  2006cites this paper
• Association of Insulin Resistance and Hematologic Parameters: Study of a Middle‐aged and Elderly Chinese Population in Taiwan

  2006cites this paper
• [Current ideas about factors responsible for renal damage in gout].

  2005cites this paper
• Some health benefits of low glycaemic index diets – a systematic review

  2005cites this paper
• The metabolic syndrome, hyperlipidemia, and insulin resistance.

  2005cites this paper
• Energy intake, meal frequency, and health: a neurobiological perspective.

  2005cites this paper
• Long-term effects of a high-protein, low-carbohydrate diet on weight control and cardiovascular risk markers in obese hyperinsulinemic subjects

  2004cites this paper
• The Assessment and Management of Antipsychotic-Associated Metabolic Disturbances from a Psychiatric Perspective

  2004cites this paper
• Meta-analysis of the health effects of using the glycaemic index in meal-planning

  2004cites this paper
• Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis Study.

  2003cites this paper
• Prevalence of Metabolic Syndrome among Hypertensive Patients Attending a Primary Care Clinic in Kuwait

  2003cites this paper
• Management of Weight Gain Associated with Antipsychotics

  2003cites this paper
• Therapeutic Potential of Insulin-Like Growth Factor-1 in Patients with Diabetes Mellitus

  2002cites this paper
• [Metabolic syndrome from the point of view of a cardiologist: diagnosis, non drug and drug treatment].

  2002cites this paper
• Bajo peso al nacimiento y síndrome metabólico

  2002cites this paper
• High protein vs high carbohydrate hypoenergetic diet in treatment of obese normoinsulinemic and hyperinsulinemic subjects

  2002cites this paper
• The role of TNF and Resistin Gene +299 (G A) Polymorphism in the Development of Insulin Resistance in non obese Type 2 Diabetes Mellitus Iraqi Patients

  2002cites this paper
• Type 2 diabetes management: A comprehensive clinical review of oral medications

  2002cites this paper
• Effects of atypical antipsychotics on weight and serum lipid levels.

  2001cites this paper
• Insulin resistance syndrome.

  2001cites this paper
• ‘Why Getting Fat, Doc?’ Weight Gain and Psychotropic Medications

  2001cites this paper
• The clinical effectiveness and cost effectiveness of rosiglitazone for type 2 diabetes mellitus: assessment report. NICE Technology Appraisal (TA9)

  2000cites this paper
• Weight gain and antipsychotic medication.

  2000cites this paper
• Remodeling of the Endocrine Pancreas: The Central Role of Amylin and Insulin Resistance

  2000cites this paper
• Impact and management of posttransplant diabetes mellitus.

  2000cites this paper
• Therapeutic approaches to insulin resistance

  2000cites this paper
• Carbohydrate Metabolism and Aging

  2000cites this paper
• Metabolic syndrome X: a review.

  2000cites this paper
• Pioglitazone

  2000cites this paper
• Improving management of type 2 diabetes mellitus: 2. Biguanides.

  1999cites this paper
• Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus

  1999cites this paper